(3.128.197.164)
Users online: 13362     
Ijournet
Email id
 

Research Journal of Pharmacy and Technology
Year : 2023, Volume : 16, Issue : 1
First page : ( 103) Last page : ( 106)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.52711/0974-360X.2023.00018

Evaluating phosphodiesterase 7B inhibition by vasicine using nuclear magnetic resonance spectroscopy

Balasundaram Arthi*, David Darling Chellathai

Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra Institute of Higher Education and Research (DU), Porur, Chennai - 116, Tamil Nadu, India

*Corresponding Author E-mail: rtms86@yahoo.com

Online Published on 10 October, 2023.

Abstract

Background

The phosphodiesterase (PDE)7B, belonging to family PDE7 has high affinity and specificity for cyclic adenosine monophosphate (cAMP). This was reported to regulate a range of physiological functions. Inhibition of this enzyme was found to have therapeutic effects. The present study aims to evaluate the inhibition of PDE7B by vasicine, using Nuclear magnetic resonance (NMR) spectroscopy.

Materials and Methods

The 1D NMR based time series experiment was performed; the initial and the final spectra were compared for the formation of cAMP in the presence and absence of the inhibitor.

Results

The PDE7B was inhibited completely by vasicine and no formation of AMP was seen in the time series spectra.

Conclusion

NMR spectroscopy method revealed the PDE7B inhibitory activity of vasicine which may be considered as a therapeutic agent for diseases regulated by cAMP.

Top

Keywords

Cyclic AMP, Quinazoline alkaloid, NMR Spectroscopy, PDE7B, In-vitro.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
750,929,419 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.